Health Care
Commentary
California should not get into the drug manufacturing business
In an attempt to lower Californians’ prescription drug costs, lawmakers just passed a bill that would allow the state government to contract with pharmaceutical manufacturers to produce generic drugs. Gov. Gavin Newsom’s signature is all but guaranteed before the end of the month. Golden State politicians aren’t the only ones ...
Commentary
Medicare for none – these are the reforms we need to keep program solvent
Democratic presidential nominee Joe Biden is proposing to expand Medicare by lowering the eligibility age from 65 to 60. But the program can’t afford the bill for its existing crop of beneficiaries, much less the $100 billion that would be required to enroll 22 million more under Biden’s plan. That’s among the conclusions to draw from a ...
Commentary
Blanket lockdowns for coronavirus are poor policy
Hundreds of health professionals recently urged government leaders to “hit the reset button” on Covid-19 by shutting the country down a second time. These blanket lockdowns pose a greater health risk to most people than the virus itself. Many Americans are so scared of Covid-19 they’ve stopped seeking medical care ...
California
Keep the government out of pharmaceutical drug manufacturing
Earlier this month, the California legislature passed a bill that would make the Golden State the first in the nation to establish its own line of generic drugs. Gov. Gavin Newsom is expected to sign the bill into law by the end of the month. The measure’s architects argue that ...
Coronavirus
The Lars Larson Show and Dr. Henry Miller Talk COVID-19 Vaccines on Hold
Dr. Henry Miller and Lars Larson talk about the latest in progress in the search for a vaccine for the coronavirus pandemic, including the recent news that AstraZeneca has paused their third-stage clinical trial for a COVID-19 vaccine due to an illness to a participant. Miller talks about how the ...
Coronavirus
Dr. Henry Miller Quoted in Reuters Vaccine Article
Title: How drugmakers can keep their pledge and still deliver an October vaccine surprise By: Michael Erman, Julie Steenhuysen, Reuters As questions mount over whether the United States will authorize a coronavirus vaccine ahead of November elections, experts say there is a slim chance that enough evidence will be available ...
Blog
California Entering Pharmaceutical Business Won’t Lower Drug Prices for Patients
The state of California, which can’t keep the lights on thanks to political interference in energy generation, nor build enough homes because government has poisoned the housing market, is going into the pharmaceutical manufacturing business. But there’s nothing to worry about. If it struggles, taxpayers will be there to bail ...
Commentary
COVID-19 Vaccines Must Be Fully Vetted For Safety And Efficacy Before Release
There is widespread anticipation of the availability of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. About four dozen, made with a variety of technology platforms, are now in clinical trials, nine in large-scale safety/efficacy testing. It was hardly a ...
Commentary
Pharmaceutical Companies Ruin Prospects for COVID-19 Vaccine “October Surprise”. That’s a Good Thing.
There is widespread anticipation of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. About four dozen, made with a variety of technology platforms, are now in clinical trials, nine in large-scale safety/efficacy testing. Vaccines have also assumed unprecedented political importance. The ...
Commentary
Coronavirus lockdown benefits remain dubious as costs continue to mount
Roughly four in ten Americans report that they experienced reduced access to medical care because of COVID-19, according to a new survey from the Centers for Disease Control and Prevention. The report is just the latest evidence that, from the standpoint of public health, the lockdowns that public officials have ...
California should not get into the drug manufacturing business
In an attempt to lower Californians’ prescription drug costs, lawmakers just passed a bill that would allow the state government to contract with pharmaceutical manufacturers to produce generic drugs. Gov. Gavin Newsom’s signature is all but guaranteed before the end of the month. Golden State politicians aren’t the only ones ...
Medicare for none – these are the reforms we need to keep program solvent
Democratic presidential nominee Joe Biden is proposing to expand Medicare by lowering the eligibility age from 65 to 60. But the program can’t afford the bill for its existing crop of beneficiaries, much less the $100 billion that would be required to enroll 22 million more under Biden’s plan. That’s among the conclusions to draw from a ...
Blanket lockdowns for coronavirus are poor policy
Hundreds of health professionals recently urged government leaders to “hit the reset button” on Covid-19 by shutting the country down a second time. These blanket lockdowns pose a greater health risk to most people than the virus itself. Many Americans are so scared of Covid-19 they’ve stopped seeking medical care ...
Keep the government out of pharmaceutical drug manufacturing
Earlier this month, the California legislature passed a bill that would make the Golden State the first in the nation to establish its own line of generic drugs. Gov. Gavin Newsom is expected to sign the bill into law by the end of the month. The measure’s architects argue that ...
The Lars Larson Show and Dr. Henry Miller Talk COVID-19 Vaccines on Hold
Dr. Henry Miller and Lars Larson talk about the latest in progress in the search for a vaccine for the coronavirus pandemic, including the recent news that AstraZeneca has paused their third-stage clinical trial for a COVID-19 vaccine due to an illness to a participant. Miller talks about how the ...
Dr. Henry Miller Quoted in Reuters Vaccine Article
Title: How drugmakers can keep their pledge and still deliver an October vaccine surprise By: Michael Erman, Julie Steenhuysen, Reuters As questions mount over whether the United States will authorize a coronavirus vaccine ahead of November elections, experts say there is a slim chance that enough evidence will be available ...
California Entering Pharmaceutical Business Won’t Lower Drug Prices for Patients
The state of California, which can’t keep the lights on thanks to political interference in energy generation, nor build enough homes because government has poisoned the housing market, is going into the pharmaceutical manufacturing business. But there’s nothing to worry about. If it struggles, taxpayers will be there to bail ...
COVID-19 Vaccines Must Be Fully Vetted For Safety And Efficacy Before Release
There is widespread anticipation of the availability of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. About four dozen, made with a variety of technology platforms, are now in clinical trials, nine in large-scale safety/efficacy testing. It was hardly a ...
Pharmaceutical Companies Ruin Prospects for COVID-19 Vaccine “October Surprise”. That’s a Good Thing.
There is widespread anticipation of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. About four dozen, made with a variety of technology platforms, are now in clinical trials, nine in large-scale safety/efficacy testing. Vaccines have also assumed unprecedented political importance. The ...
Coronavirus lockdown benefits remain dubious as costs continue to mount
Roughly four in ten Americans report that they experienced reduced access to medical care because of COVID-19, according to a new survey from the Centers for Disease Control and Prevention. The report is just the latest evidence that, from the standpoint of public health, the lockdowns that public officials have ...
